Bacterial invasion of vascular cell types: vascular infectology and atherogenesis

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Katz JT, Shannon RP. Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation113(7),920–922 (2006).
  MedlineGoogle Scholar
• 2  Van Dyke TE, Kornman KS. Inflammation and factors that may regulate inflammatory response. J. Periodontol.79(Suppl. 8),1503–1507 (2008).▪ Review of inflammatory processes underlying chronic diseases.
  Medline CASGoogle Scholar
• 3  Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol.54(23),2129–2138 (2009).▪▪ Presents the role of innate and adaptive arms of inflammatory response in atheroma formation and complication.
  Medline CASGoogle Scholar
• 4  Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J.74(2),213–220 (2010).
  Medline CASGoogle Scholar
• 5  Gilbert A, Lion, G. Arterites infectieuses experimentales. CR Hebd Sciences Mem. Soc. Biol.41,583–584 (1889).
  Google Scholar
• 6  Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J. Exp. Med.148(1),335–340 (1978).
  Medline CASGoogle Scholar
• 7  Ross R. Atherosclerosis – an inflammatory disease. N. Engl. J. Med.340(2),115–126 (1999).
  Medline CASGoogle Scholar
• 8  Grau AJ, Marquardt L, Lichy C. The effect of infections and vaccinations on stroke risk. Expert Rev. Neurother.6(2),175–183 (2006).
  MedlineGoogle Scholar
• 9  Epstein SE, Zhu J, Najafi AH, Burnett MS. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation119(24),3133–3141 (2009).▪▪ Reviews the concept that infections underlie atherogenesis and plaque rupture and of the potential mechanisms of such effects.
  Medline CASGoogle Scholar
• 10  Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation105(9),1135–1143 (2002).
  Medline CASGoogle Scholar
• 11  Ridker PM. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation105(1),2–4 (2002).
  MedlineGoogle Scholar
• 12  Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet2(8618),983–986 (1988).
  Medline CASGoogle Scholar
• 13  Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation105(1),15–21 (2002).
  MedlineGoogle Scholar
• 14  Frostegard J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clin. Immunol.134(1),47–54 (2010).
  MedlineGoogle Scholar
• 15  Elkind MS. Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect. Disord. Drug Targets10(2),84–90 (2010).
  Medline CASGoogle Scholar
• 16  Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J. Clin. Periodontol.36(Suppl. 10),15–19 (2009).
  MedlineGoogle Scholar
• 17  Kebschull M, Demmer RT, Papapanou PN. “Gum bug, leave my heart alone!” – epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res.89(9),879–902 (2010).▪ Reviews the knowledge on the impact of periodontal disease to systemic inflammations.
  Medline CASGoogle Scholar
• 18  Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter. J. Am. Dent. Assoc.137(Suppl.),14S–20S; quiz 38S (2006).▪ Reviews the epidemiological link between periodontitis and cardiovascular disease, addressing the confounding of risk factors and the benefits of a convergence of oral and medical care.
  MedlineGoogle Scholar
• 19  Zoellner H. Dental infection and vascular disease. Semin. Thromb. Hemost.37(3),181–192 (2011).
  MedlineGoogle Scholar
• 20  Desvarieux M, Demmer RT, Rundek T et al. Periodontal microbiota and carotid intima-media thickness: the oral infections and vascular disease epidemiology study (INVEST). Circulation111(5),576–582 (2005).
  MedlineGoogle Scholar
• 21  Renvert S, Pettersson T, Ohlsson O, Persson GR. Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J. Periodontol.77(7),1110–1119 (2006).
  Medline CASGoogle Scholar
• 22  Engebretson SP, Lamster IB, Elkind MS et al. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke36(3),561–566 (2005).
  MedlineGoogle Scholar
• 23  Nonnenmacher C, Stelzel M, Susin C et al. Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J. Periodontol.78(9),1724–1730 (2007).
  MedlineGoogle Scholar
• 24  Volzke H, Schwahn C, Hummel A et al. Tooth loss is independently associated with the risk of acquired aortic valve sclerosis. Am. Heart J.150(6),1198–1203 (2005).
  MedlineGoogle Scholar
• 25  Mattila KJ, Pussinen PJ, Paju S. Dental infections and cardiovascular diseases: a review. J. Periodontol.76(Suppl. 11),2085–2088 (2005).
  MedlineGoogle Scholar
• 26  Yamazaki K, Honda T, Domon H et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin. Exp. Immunol.149(3),445–452 (2007).
  Medline CASGoogle Scholar
• 27  Pesonen E, El-Segaier M, Persson K et al. Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Ther. Adv. Cardiovasc. Dis.3(6),447–454 (2009).
  MedlineGoogle Scholar
• 28  Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA. Antibodies to periodontal pathogens and coronary artery calcification in Type 1 diabetic and nondiabetic subjects. J. Periodontal Res.43(1),103–110 (2008).
  Medline CASGoogle Scholar
• 29  Tew JG, El Shikh ME, El Sayed RM, Schenkein HA. Dendritic cells, antibodies reactive with oxLDL, and inflammation. J. Dent. Res. doi:10.1177/0022034511407338 (2011) (Epub ahead of print).
  MedlineGoogle Scholar
• 30  Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J. Periodontol.78(12),2289–2302 (2007).
  MedlineGoogle Scholar
• 31  Jimenez M, Krall EA, Garcia RI, Vokonas PS, Dietrich T. Periodontitis and incidence of cerebrovascular disease in men. Ann. Neurol.66(4),505–512 (2009).
  MedlineGoogle Scholar
• 32  Hayashi C, Gudino CV, Gibson FC 3rd, Genco CA. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol. Oral Microbiol.25(5),305–316 (2010).▪ Analysis of the mechanisms by which oral bacteria can induce and maintain a chronic inflammation at distant sites.
  Medline CASGoogle Scholar
• 33  Teles R, Wang CY. Mechanisms involved in the association between peridontal diseases and cardiovascular disease. Oral Dis.17(5),450–461 (2011).▪ Overview of the avenues by which periodontal bacteria can induce a chronic vascular inflammation.
  Medline CASGoogle Scholar
• 34  Iwai T. Periodontal bacteremia and various vascular diseases. J. Periodontal Res.44(6),689–694 (2009).
  Medline CASGoogle Scholar
• 35  Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J. Clin. Periodontol.32(7),708–713 (2005).
  MedlineGoogle Scholar
• 36  Lockhart PB, Brennan MT, Thornhill M et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J. Am. Dent. Assoc.140(10),1238–1244 (2009).
  MedlineGoogle Scholar
• 37  Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev.65(12 Pt 2),S140–S146 (2007).
  MedlineGoogle Scholar
• 38  Andrew P, Montenero AS. Is there a link between atrial fibrillation and certain bacterial infections? J. Cardiovasc. Med. (Hagerstown)8(12),990–996 (2007).
  MedlineGoogle Scholar
• 39  Campbell LA, Kuo CC. Chlamydia pneumoniae – an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol.2(1),23–32 (2004).
  Medline CASGoogle Scholar
• 40  Vainas T, Stassen FR, Schurink GW et al. Secondary prevention of atherosclerosis through Chlamydia pneumoniae eradication (SPACE Trial): a randomized clinical trial in patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg.29(4),403–411 (2005).
  Medline CASGoogle Scholar
• 41  Nicolle L. Chlamydia pneumoniae and atherosclerosis: the end? Can. J. Infect. Dis. Med. Microbiol.16(5),267–268 (2005).▪ Analysis of the consequences of the failed antibiotic clinical trials.
  Medline CASGoogle Scholar
• 42  Joensen JB, Juul S, Henneberg E, Thomsen G, Ostergaard L, Lindholt JS. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial. Atherosclerosis196(2),937–942 (2008).
  Medline CASGoogle Scholar
• 43  Harskamp RE, van Ginkel MW. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann. Med.40(2),121–128 (2008).
  MedlineGoogle Scholar
• 44  Elkind MSV, Ramakrishnan P, Moon YP et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch. Neurol.67(1),33–38 (2010).▪ Presentation of the concept of ‘infectious burden’, associated with the risk of stroke and carotid atherosclerosis.
  MedlineGoogle Scholar
• 45  Elkind MS, Luna JM, Moon YP et al. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke41(3),e117–e122 (2010).
  MedlineGoogle Scholar
• 46  Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol.2(9),747–765 (2004).
  Medline CASGoogle Scholar
• 47  Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis.3(9),578–590 (2003).
  Medline CASGoogle Scholar
• 48  Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect.8(3),687–693 (2006).
  Medline CASGoogle Scholar
• 49  Ott SJ, El Mokhtari NE, Musfeldt M et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation113(7),929–937 (2006).
  MedlineGoogle Scholar
• 50  Lewis K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol.5(1),48–56 (2007).
  Medline CASGoogle Scholar
• 51  Lidar M, Lipschitz N, Langevitz P, Shoenfeld Y. The infectious etiology of vasculitis. Autoimmunity42(5),432–438 (2009).
  MedlineGoogle Scholar
• 52  Zeituni AE, Carrion J, Cutler CW. Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease. J. Oral Microbiol.2, doi:10.3402/jom.v2i0.5782 (2010).▪ Important experimental paper supporting the notion that bacteria from focal periodontal lesion may exploit phagocytic cells to gain access to systemic circulation.
  MedlineGoogle Scholar
• 53  Pollreisz A, Huang Y, Roth GA et al. Enhanced monocyte migration and proinflammatory cytokine production by Porphyromonas gingivalis infection. J. Periodontal Res.45(2),239–245 (2010).
  Medline CASGoogle Scholar
• 54  Chavakis T, Wiechmann K, Preissner KT, Herrmann M. Staphylococcus aureus interactions with the endothelium: the role of bacterial ‘secretable expanded repertoire adhesive molecules’ (SERAM) in disturbing host defense systems. Thromb. Haemost.94(2),278–285 (2005).
  Medline CASGoogle Scholar
• 55  Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev.73(3),407–450, Table of Contents (2009).
  Medline CASGoogle Scholar
• 56  Amano A. Bacterial adhesins to host components in periodontitis. Periodontol. 200052(1),12–37 (2010).
  MedlineGoogle Scholar
• 57  Tribble GD, Lamont RJ. Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol. 200052(1),68–83 (2010).
  MedlineGoogle Scholar
• 58  Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun.66(11),5337–5343 (1998).
  Medline CASGoogle Scholar
• 59  Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun.67(11),5792–5798 (1999).
  Medline CASGoogle Scholar
• 60  Dorn BR, Dunn WA Jr, Progulske-Fox A. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect. Immun.69(9),5698–5708 (2001).
  Medline CASGoogle Scholar
• 61  Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol. Lett.272(1),106–113 (2007).
  Medline CASGoogle Scholar
• 62  Li L, Michel R, Cohen J, DeCarlo A, Kozarov E. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiol.8,26–36 (2008).
  Medline CASGoogle Scholar
• 63  Abranches J, Zeng L, Belanger M et al. Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol. Immunol.24(2),141–145 (2009).
  Medline CASGoogle Scholar
• 64  Nakano K, Inaba H, Nomura R et al. Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J. Clin. Microbiol.44(9),3313–3317 (2006).
  Medline CASGoogle Scholar
• 65  Chi F, Jong TD, Wang L et al. Vimentin-mediated signalling is required for IbeA⁺E. coli K1 invasion of human brain microvascular endothelial cells. Biochem. J.427(1),79–90 (2010).
  Medline CASGoogle Scholar
• 66  Rodrigues PH, Belanger M, Dunn W Jr, Progulske-Fox A. Porphyromonas gingivalis and the autophagic pathway: an innate immune interaction? Front. Biosci.13,178–187 (2008).
  Medline CASGoogle Scholar
• 67  Huang J, Brumell JH. Autophagy in immunity against intracellular bacteria. Curr. Top Microbiol. Immunol.335,189–215 (2009).
  Medline CASGoogle Scholar
• 68  Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell. Microbiol.12(8),1026–1035 (2010).
  Medline CASGoogle Scholar
• 69  Vazquez CL, Colombo MI. Beclin 1 modulates the antiapoptotic activity of Bcl-2: insights from a pathogen infection system. Autophagy6(1),177–178 (2010).
  MedlineGoogle Scholar
• 70  Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol.7(10),767–777 (2007).
  Medline CASGoogle Scholar
• 71  Yilmaz O, Verbeke P, Lamont RJ, Ojcius DM. Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect. Immun.74(1),703–710 (2006).
  Medline CASGoogle Scholar
• 72  Stassen FR, Vainas T, Bruggeman CA. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol. Rep.60(1),85–92 (2008).
  Medline CASGoogle Scholar
• 73  Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. (London)117(3),95–109 (2009).
  Medline CASGoogle Scholar
• 74  Hajishengallis G, Tapping RI, Harokopakis E et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol.8(10),1557–1570 (2006).▪ Comprehensive study on the receptor-mediated mechanism of bacteria-activated cell signaling.
  Medline CASGoogle Scholar
• 75  Khlgatian M, Nassar H, Chou HH, Gibson FC 3rd, Genco CA. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun.70(1),257–267 (2002).
  Medline CASGoogle Scholar
• 76  Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd, Genco CA. Fimbria-dependent activation of proinflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell. Microbiol.8(5),738–757 (2006).
  Medline CASGoogle Scholar
• 77  Chou HH, Yumoto H, Davey M et al. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect. Immun.73(9),5367–5378 (2005).
  Medline CASGoogle Scholar
• 78  Martinet W, Schrijvers DM, De Meyer GR. Necrotic cell death in atherosclerosis. Basic Res. Cardiol. (2011).
  MedlineGoogle Scholar
• 79  Kozarov E, Li L, Michel R, Rodriguez R, DeCarlo AA. Differential activity of P. gingivalis-secreted proteins toward polarized human endothelial cells. J. Dental Res.82(Special Issue B),B180 (2003).
  Google Scholar
• 80  Roth GA, Aumayr K, Giacona MB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. Thromb. Res.123(5),780–784 (2009).▪ Demonstrates prothrombotic effects of smooth muscle cell-associated periodontal bacteria.
  Medline CASGoogle Scholar
• 81  Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases – from molecular mechanisms to clinical cases: involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J. Pharmacol. Sci.113(2),115–119 (2010).
  Medline CASGoogle Scholar
• 82  Herzberg MC, Nobbs A, Tao L et al. Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J. Periodontol.76(Suppl. 11),2101–2105 (2005).
  MedlineGoogle Scholar
• 83  Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation122(18),1862–1875 (2010).
  MedlineGoogle Scholar
• 84  Sato Y, Kishi J, Suzuki K, Nakamura H, Hayakawa T. Sonic extracts from a bacterium related to periapical disease activate gelatinase A and inactivate tissue inhibitor of metalloproteinases TIMP-1 and TIMP-2. Int. Endod. J.42(12),1104–1111 (2009).
  Medline CASGoogle Scholar
• 85  Guan SM, Shu L, Fu SM, Liu B, Xu XL, Wu JZ. Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. FEMS Microbiol. Lett.299(2),214–222 (2009).
  Medline CASGoogle Scholar
• 86  Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol.35(2),89–105 (2008).
  MedlineGoogle Scholar
• 87  Gibson FC 3rd, Hong C, Chou HH et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation109(22),2801–2806 (2004).
  Medline CASGoogle Scholar
• 88  Amar S, Wu SC, Madan M. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J. Immunol.182(3),1584–1592 (2009).▪ Rare animal model study at the intersection of immunology and pharmacology suggesting that drug regimens could be useful for treatment of atherosclerosis.
  Medline CASGoogle Scholar
• 89  Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J. Bacteriol.192(19),5002–5017 (2010).▪ Most comprehensive description to date of the human oral microbiome.
  Medline CASGoogle Scholar
• 90  Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. Exploring the oral bacterial flora: current status and future directions. Oral Dis.16(2),136–145 (2010).
  Medline CASGoogle Scholar
• 91  Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann. Periodontol.7(1),79–89 (2002).
  MedlineGoogle Scholar
• 92  Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol.71(10),1554–1560. (2000).
  Medline CASGoogle Scholar
• 93  Bahrani-Mougeot FK, Paster BJ, Coleman S et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J. Clin. Microbiol.45(5),1588–1593 (2007).
  Medline CASGoogle Scholar
• 94  Cole JR, Chai B, Farris RJ et al. The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res.35(Database issue),D169–D172 (2007).
  Medline CASGoogle Scholar
• 95  Padilla C, Lobos O, Hubert E et al. Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J. Periodontal Res.41(4),350–353 (2006).
  Medline CASGoogle Scholar
• 96  Koren O, Spor A, Felin J et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA108(Suppl. 1),4592–4598 (2011).
  Medline CASGoogle Scholar
• 97  Ford PJ, Gemmell E, Chan A et al. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol. Immunol.21(4),206–211 (2006).
  Medline CASGoogle Scholar
• 98  Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV. Identification of periodontal pathogens in atherosclerotic vessels. J. Periodontol.76(5),731–736 (2005).
  Medline CASGoogle Scholar
• 99  Kozarov E, Dorn B, Shelburne C, Dunn W, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Arterioscler. Thromb. Vasc. Biol.25(3),e17–e18 (2005).
  Medline CASGoogle Scholar
• 100  Kusner DJ. Mechanisms of mycobacterial persistence in tuberculosis. Clin. Immunol.114(3),239–247 (2005).
  Medline CASGoogle Scholar
• 101  Steinert M, Emody L, Amann R, Hacker J. Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl. Environ. Microbiol.63(5),2047–2053 (1997).
  Medline CASGoogle Scholar
• 102  Schoedon G, Goldenberger D, Forrer R et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J. Infect. Dis.176(3),672–677 (1997).
  Medline CASGoogle Scholar
• 103  Rafferty B, Jönsson D, Kalachikov S et al. Impact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions. J. Intern. Med.270(3),273–280 (2011).
  Medline CASGoogle Scholar
• 104  Fujii R, Saito Y, Tokura Y, Nakagawa KI, Okuda K, Ishihara K. Characterization of bacterial flora in persistent apical periodontitis lesions. Oral Microbiol. Immunol.24(6),502–505 (2009).
  Medline CASGoogle Scholar
• 105  Debelian GJ, Olsen I, Tronstad L. Anaerobic bacteremia and fungemia in patients undergoing endodontic therapy: an overview. Ann. Periodontol.3(1),281–287 (1998).
  Medline CASGoogle Scholar
• 106  Caplan DJ, Pankow JS, Cai J, Offenbacher S, Beck JD. The relationship between self-reported history of endodontic therapy and coronary heart disease in the Atherosclerosis Risk in Communities Study. J. Am. Dent. Assoc.140(8),1004–1012 (2009).
  MedlineGoogle Scholar
• 107  Nataloni M, Pergolini M, Rescigno G, Mocchegiani R. Prosthetic valve endocarditis. J. Cardiovasc. Med. (Hagerstown)11(12),869–883 (2010).
  MedlineGoogle Scholar
• 108  Rafferty B, Dolgilevich S, Kalachikov S et al. Cultivation of Enterobacter hormaechei from human atherosclerotic tissue. J. Atheroscler. Thromb.18(1),72–81 (2011).
  Medline CASGoogle Scholar
• 109  D’Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J.151(5),977–984 (2006).
  MedlineGoogle Scholar
• 110  Tonetti MS, D’Aiuto F, Nibali L et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med.356(9),911–920 (2007).
  Medline CASGoogle Scholar
• 111  Seinost G, Wimmer G, Skerget M et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am. Heart J.149(6),1050–1054 (2005).
  MedlineGoogle Scholar
• 112  Papapanou PN, Sedaghatfar MH, Demmer RT et al. Periodontal therapy alters gene expression of peripheral blood monocytes. J. Clin. Periodontol.34(9),736–747 (2007).
  Medline CASGoogle Scholar
• 113  Lalla E, Kaplan S, Yang J, Roth GA, Papapanou PN, Greenberg S. Effects of periodontal therapy on serum C-reactive proteins, E-selectin, and tumor necrosis factor-alpha secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J. Periodontal Res.42(3),274–282 (2007).
  Medline CASGoogle Scholar
• 114  Piconi S, Trabattoni D, Luraghi C et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J.23(4),1196–1204 (2009).
  Medline CASGoogle Scholar
• 115  Paju S, Pussinen PJ, Sinisalo J et al. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. Atherosclerosis188(2),412–419 (2006).
  Medline CASGoogle Scholar
• 116  Paju S, Sinisalo J, Pussinen PJ, Valtonen V, Nieminen MS. Is periodontal infection behind the failure of antibiotics to prevent coronary events? Atherosclerosis193(1),193–195 (2007).
  Medline CASGoogle Scholar
• 117  Scannapieco FA, Dasanayake AP, Chhun N. Does periodontal therapy reduce the risk for systemic diseases? Dent. Clin. North Am.54(1),163–181 (2010).
  MedlineGoogle Scholar
• 118  Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat. Rev. Gastroenterol. Hepatol.8(2),79–88 (2011).
  Medline CASGoogle Scholar
• 119  Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1(8390),1311–1315 (1984).
  Medline CASGoogle Scholar
• 120  Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta1793(4),664–673 (2009).
  Medline CASGoogle Scholar
• 121  Lerena MC, Vazquez CL, Colombo MI. Bacterial pathogens and the autophagic response. Cell. Microbiol.12(1),10–18 (2010).
  Medline CASGoogle Scholar
• 122  Travassos LH, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol.11(1),55–62 (2010).
  Medline CASGoogle Scholar
• 123  Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science311(5768),1770–1773 (2006).
  Medline CASGoogle Scholar
• 124  Yuk JM, Shin DM, Lee HM et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe6(3),231–243 (2009).
  Medline CASGoogle Scholar
• 125  Foster LJ, Chan QW. Lipid raft proteomics: more than just detergent-resistant membranes. Subcell. Biochem.43,35–47 (2007).
  MedlineGoogle Scholar
• 126  Seveau S, Pizarro-Cerda J, Cossart P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes Infect.9(10),1167–1175 (2007).
  Medline CASGoogle Scholar
• 127  Zaas DW, Duncan M, Rae Wright J, Abraham SN. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim. Biophys. Acta1746(3),305–313 (2005).
  Medline CASGoogle Scholar
• 128  Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature473(7347),317–325 (2011).
  Medline CASGoogle Scholar
• 129  Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis.3(9),578–590 (2003).
  Medline CASGoogle Scholar
• 130  Domingue GJ Sr, Woody HB. Bacterial persistence and expression of disease. Clin. Microbiol. Rev.10(2),320–344 (1997).
  MedlineGoogle Scholar
• 131  Garduno RA, Garduno E, Hiltz M, Hoffman PS. Intracellular growth of Legionella pneumophila gives rise to a differentiated form dissimilar to stationary-phase forms. Infect. Immun.70(11),6273–6283 (2002).
  Medline CASGoogle Scholar
• 132  Lin MY, Ottenhoff TH. Host–pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr. Metab. Immune Disord. Drug Targets8(1),15–29 (2008).
  Medline CASGoogle Scholar
• 133  Lin MY, Geluk A, Smith SG et al. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect. Immun.75(7),3523–3530 (2007).
  Medline CASGoogle Scholar
• 201  American Heart Association. www.americanheart.org
  Google Scholar
• 202  Ribosomal Database Project. http://rdp.cme.msu.edu/index.jsp
  Google Scholar